Taneli Jouhikainen
2019
In 2019, Taneli Jouhikainen earned a total compensation of $1M as Chief Operating Officer & President at Mast Therapeutics, a 74% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $201,338 |
|---|---|
| Option Awards | $240,941 |
| Salary | $546,000 |
| Other | $22,000 |
| Total | $1,010,279 |
Jouhikainen received $546K in salary, accounting for 54% of the total pay in 2019.
Jouhikainen also received $201.3K in non-equity incentive plan, $240.9K in option awards and $22K in other compensation.
Rankings
In 2019, Taneli Jouhikainen's compensation ranked 9,213th out of 13,971 executives tracked by ExecPay. In other words, Jouhikainen earned more than 34.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,213 out of 13,971 | 34th |
Division Manufacturing | 3,691 out of 5,701 | 35th |
Major group Chemicals And Allied Products | 1,402 out of 2,200 | 36th |
Industry group Drugs | 1,195 out of 1,886 | 37th |
Industry Pharmaceutical Preparations | 888 out of 1,398 | 37th |
Source: SEC filing on April 15, 2020.
Jouhikainen's colleagues
We found two more compensation records of executives who worked with Taneli Jouhikainen at Mast Therapeutics in 2019.